###begin article-title 0
###xml 49 53 49 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 80 85 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The host protein Staufen1 interacts with the Pr55Gag zinc fingers and regulates HIV-1 assembly via its N-terminus
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 158 162 158 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 423 426 423 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 478 482 478 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 69 74 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 444 449 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The formation of new infectious human immunodeficiency type 1 virus (HIV-1) mainly relies on the homo-multimerization of the viral structural polyprotein Pr55Gag and on the recruitment of host factors. We have previously shown that the double-stranded RNA-binding protein Staufen 1 (Stau1), likely through an interaction between its third double-stranded RNA-binding domain (dsRBD3) and the nucleocapsid (NC) domain of Pr55Gag, participates in HIV-1 assembly by influencing Pr55Gag multimerization.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 44 48 44 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 213 217 213 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 316 320 316 320 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 425 429 425 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 563 567 563 567 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 597 600 597 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 605 609 605 609 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 763 767 763 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 895 898 895 898 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
We now report the fine mapping of Stau1/Pr55Gag association using co-immunoprecipitation and live cell bioluminescence resonance energy transfer (BRET) assays. On the one hand, our results show that the Stau1-Pr55Gag interaction requires the integrity of at least one of the two zinc fingers in the NC domain of Pr55Gag but not that of the NC N-terminal basic region. Disruption of both zinc fingers dramatically impeded Pr55Gag multimerization and virus particle release. In parallel, we tested several Stau1 deletion mutants for their capacity to influence Pr55Gag multimerization using the Pr55Gag/Pr55Gag BRET assay in live cells. Our results revealed that a molecular determinant of 12 amino acids at the N-terminal end of Stau1 is necessary to increase Pr55Gag multimerization and particle release. However, this region is not required for Stau1 interaction with the viral polyprotein Pr55Gag.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 83 87 83 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 152 156 152 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 298 303 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
These data highlight that Stau1 is a modular protein and that Stau1 influences Pr55Gag multimerization via 1) an interaction between its dsRBD3 and Pr55Gag zinc fingers and 2) a regulatory domain within the N-terminus that could recruit host machineries that are critical for the completion of new HIV-1 capsids.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 214 218 214 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 316 317 316 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 318 319 318 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 326 330 326 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 433 437 433 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 571 572 571 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 573 574 573 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 581 585 581 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 917 918 917 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 919 920 919 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1061 1062 1061 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1063 1065 1063 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 31 36 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 564 569 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 765 770 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Human immunodeficiency type 1 (HIV-1) assembly consists in the formation of new viral particles which is the result of the radial multimerization of approximately 1,400 to 5,000 copies of the viral polyprotein Pr55Gag (also named Gag) according to their quantification in mature or immature particles, respectively [1-3]. Pr55Gag is thought to contain most of the determinants required for viral assembly since the expression of Pr55Gag alone leads to the formation and release of virus-like particles (VLPs), structurally not really distinguishable from immature HIV-1 [4-6]. Pr55Gag is a modular protein that contains 6 domains: matrix (MA), capsid (CA), nucleocapsid (NC), p6 and two spacer peptides, p2 and p1. Each of these domains plays specific roles during HIV-1 life cycle. During assembly, the MA domain, through its myristylated moiety and its highly basic domain, anchors assembly complexes to membranes [4-6]. Whether assembly takes place at the inner leaflet of the plasma membrane or at the multivesicular bodies (or both) is still under debate [7-17].
###end p 9
###begin p 10
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 88 92 88 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 129 131 129 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 271 275 271 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 389 391 389 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 524 531 524 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 591 595 591 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 718 722 718 722 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 783 784 783 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 785 786 785 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 903 905 903 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 906 908 906 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 997 1001 997 1001 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1250 1252 1250 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1253 1255 1253 1255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1256 1258 1256 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 478 483 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 621 626 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1234 1239 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Pr55Gag multimerization is likely initiated by NC/NC contacts [18,19] probably when Pr55Gag is still in a cytosolic compartment [20-23]. The basic amino acid stretch present in NC is thought to non-specifically recruit RNA that serves as a scaffold for multimerizing Pr55Gag [24-26]. Indeed, mutations abrogating the global positive charge of this sub-domain compromise viral assembly [24,25]. NC also possesses two zinc fingers that are important for the specific packaging of HIV-1 genomic RNA [27-29]. Recently, Grigorov et al. demonstrated the involvement of both NC zinc fingers in Pr55Gag cellular localization and HIV-1 assembly [30]. Similarly, the first NC zinc finger was shown to be part of the minimal Pr55Gag sequence required for multimerization (called the I domain) [5,6]. Since NC function during assembly can be mimicked by its substitution with a heterologous oligomerization domain [31,32], NC/NC contacts probably serve as a signal for the higher order multimerization of Pr55Gag under the control of other domains. Indeed, the C-terminal third of the CA domain and the spacer peptide p2 are part of the I domain and have been shown by mutagenesis and structural analyses to be also very important players during HIV-1 assembly [26,33-42].
###end p 10
###begin p 11
###xml 256 257 256 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 351 355 351 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 425 429 425 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 502 506 502 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 584 588 584 588 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 595 597 595 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 727 731 727 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 814 816 814 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 4 9 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The HIV-1 assembly process within the cell appears to be tightly regulated in time and space and relies on the sequential acquisition and release of host proteins that are required for the cellular localization, multimerization and budding of new capsids [4,43]. For instance, the ATP-binding protein ABCE1/HP68 is important for the completion of Pr55Gag multimerization via a transient interaction with the NC domain of Pr55Gag [44-47]. Adaptor proteins 1, 2, 3 (AP-1; AP-2; AP-3) are involved in Pr55Gag intracellular trafficking through their association with the MA domain of Pr55Gag [12,48,49]. Finally, endosomal sorting complex required for transport (ESCRT)-I and -III machineries are recruited by the p6 domain of Pr55Gag and are crucial for the budding and release of the neosynthesized viral particles [50].
###end p 11
###begin p 12
###xml 31 34 31 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 86 88 86 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 632 634 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 67 72 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Staufen1 (Stau1) is also a Pr55Gag-binding protein that influences HIV-1 assembly [51-53]. Stau1 belongs to the double-stranded RNA-binding protein family [54,55] and is involved in various cellular processes related to RNA. Stau1 was first studied for its role in the transport and localization of mRNAs in dendrites of neurons [56]. More recently, Stau1 was identified as a central component of a new mRNA decay mechanism termed Staufen-mediated decay [57]. In addition to its functions in RNA localization and decay, Stau1 can also stimulate translation of repressed messengers containing structured RNA elements in their 5'UTR [58].
###end p 12
###begin p 13
###xml 68 70 68 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 154 158 154 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 551 555 551 555 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 572 574 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 601 605 601 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 840 844 840 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 926 930 926 930 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1014 1018 1014 1018 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1225 1228 1225 1228 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 61 66 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 96 101 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 222 227 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 300 305 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 382 387 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 443 448 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 517 522 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1094 1099 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1215 1220 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Stau1 is a host factor that is selectively encapsidated into HIV-1 [53]. Stau1 co-purifies with HIV-1 genomic RNA and interacts with the NC domain of Pr55Gag [52,53] suggesting that Stau1 assists NC's functions during the HIV-1 replication cycle. Stau1 levels in the producer cells are important for HIV-1 since both Stau1 overexpression and depletion using RNA interference affect HIV-1 infectivity [52,53]. In addition to a putative role in HIV-1 genomic RNA packaging [53], we recently showed that Stau1 modulates HIV-1 assembly by influencing Pr55Gag multimerization [51]. Indeed, using a new Pr55Gag multimerization assay relying on bioluminescence resonance energy transfer (BRET), we demonstrated that both Stau1 overexpression and depletion enhanced multimerization and consequently increased VLP production. Although Stau1 and Pr55Gag interact in both cytosolic and membrane compartments, this effect of Stau1 on Pr55Gag oligomerization was only observed in membranes, a cellular compartment in which Pr55Gag assembly primarily occurs. However, the mechanism by which Stau1 influences HIV-1 assembly at the molecular level remains unknown although it is likely that it relies on the Stau1 interaction with HIV-1 Pr55Gag.
###end p 13
###begin p 14
###xml 70 74 70 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 116 120 116 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 264 268 264 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 344 348 344 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 450 454 450 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 485 488 485 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 493 497 493 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 665 669 665 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 797 800 797 800 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 334 339 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 912 917 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Using co-immunoprecipitation and BRET assays, we showed that both Pr55Gag NC zinc fingers are involved in Stau1/Pr55Gag interaction as does the Stau1 dsRBD3 [52]. Unexpectedly, we found that the binding of Stau1 to NC is not sufficient per se to fully enhance Pr55Gag multimerization. To determine which domain of Stau1 modulates the HIV-1 Pr55Gag multimerization process, we analyzed several Stau1 deletion mutants for their capacity to enhance Pr55Gag multimerization. Using the Pr55Gag/Pr55Gag BRET assay either in live cells or after cell fractionation, we showed that the first 88 amino acids at the N-terminal of Stau1 confer the capacity to enhance both Pr55Gag multimerization and VLP production. Although unable to enhance multimerization, this mutant was still able to interact with Pr55Gag. This study provides important new information about the molecular determinants required for Stau1 function in HIV-1 assembly.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
Cell culture and reagents
###end title 16
###begin p 17
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 138 142 <span type="species:ncbi:9913">calf</span>
###xml 369 374 <span type="species:ncbi:10090">mouse</span>
###xml 379 385 <span type="species:ncbi:9986">rabbit</span>
Human embryonic kidney fibroblasts (HEK 293T) were cultured in Dulbecco's Modified Eagle Medium (Invitrogen) supplemented with 10% cosmic calf serum (HyClone) and 1% penicillin/streptomycin antibiotics (Multicell). Transfections were carried out using either the calcium phosphate precipitation method or the Lipofectamine 2000 reagent (Invitrogen). For Western blots, mouse and rabbit HRP-coupled secondary antibodies were purchased from Dako Cytomation and signals were detected using the Western Lightning Chemiluminescence Reagent Plus (PerkinElmer Life Sciences). Signals were detected with a Fluor-S MultiImager apparatus (Bio-Rad). Anti-Na-K ATPase antibodies were kindly provided by Dr. Michel Bouvier.
###end p 17
###begin title 18
Plasmid construction
###end title 18
###begin p 19
###xml 36 38 36 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 41 42 41 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 60 65 60 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F135A</sup>
###xml 68 69 68 69 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 86 95 86 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 98 99 94 95 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 111 113 107 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 129 134 125 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F135A</sup>
###xml 150 159 146 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 175 186 167 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;dsRBD3</sup>
###xml 201 204 189 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 205 206 193 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 220 223 208 211 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 265 266 253 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 291 293 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 294 296 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 297 299 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 352 356 340 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 389 391 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 392 394 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 395 397 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 27 30 <span type="species:ncbi:11886?0.2234143262858946">RSV</span>
###xml 51 54 <span type="species:ncbi:11886?0.2234143262858946">RSV</span>
###xml 77 80 <span type="species:ncbi:11886?0.2234143262858946">RSV</span>
The construction of pcDNA3-RSV-Stau155-HA3, pcDNA3-RSV-Stau1F135A-HA3, pcDNA-RSV-Stau1DeltaNt88-HA3, pCMV-Stau155-YFP, pCMV-Stau1F135A-YFP, pCMV-Stau1DeltaNt88-YFP, pCMV-Stau1DeltadsRBD3-YFP, pCMV-Pr55Gag-Rluc, pCMV-Pr55Gag-YFP, pCMV-NC-p1-YFP and pCMV-CA-p2-NC-p1-Rluc was reported before [51-54,59]. The HxBRU PR-provirus and the Rev-independent Pr55Gag expressor were described before [51,53,60].
###end p 19
###begin p 20
###xml 28 37 28 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt37</sup>
###xml 40 41 36 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 113 115 109 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 118 120 114 116 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 374 377 370 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kpn</italic>
###xml 383 386 379 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 445 448 441 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kpn</italic>
###xml 450 453 446 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xba</italic>
###xml 19 22 <span type="species:ncbi:11886?0.2234143262858946">RSV</span>
###xml 104 107 <span type="species:ncbi:11886?0.2234143262858946">RSV</span>
###xml 474 477 <span type="species:ncbi:11886?0.2234143262858946">RSV</span>
To construct pcDNA-RSV-Stau1DeltaNt37-HA3, a polymerase chain reaction (PCR) was performed using pcDNA3-RSV-Stau155-HA3 as template, sense (5'-ATCAGGTACCATGGGTCCATTTCCAGTTCCACCTTT-3') and anti-sense (5'-CACATCTAGATCATTTATTCAGCGGCCGCACTGAGCAGCGT-3') oligonucleotide primers and the Phusion DNA polymerase (New England Biolabs). The PCR product was purified and digested with KpnI and XbaI restriction enzymes (Fermentas) and then cloned into the KpnI/XbaI cassette of pCDNA3-RSV.
###end p 20
###begin p 21
###xml 27 29 27 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 184 187 184 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Not</italic>
###xml 213 215 213 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 218 220 218 220 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 289 298 289 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 309 313 305 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EcoR</italic>
###xml 342 351 338 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 354 356 346 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 415 419 407 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">EcoR</italic>
###xml 445 447 437 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 18 21 <span type="species:ncbi:11886?0.2234143262858946">RSV</span>
###xml 204 207 <span type="species:ncbi:11886?0.2234143262858946">RSV</span>
###xml 280 283 <span type="species:ncbi:11886?0.2234143262858946">RSV</span>
###xml 333 336 <span type="species:ncbi:11886?0.2234143262858946">RSV</span>
###xml 436 439 <span type="species:ncbi:11886?0.2234143262858946">RSV</span>
To generate pcDNA-RSV-Stau155-Flag plasmid, oligonucleotides (5'-GGCCTTGATTACAAGGATGACGATGACAAG-3' and 5'-GGCCCTTGTCATCGTCATCCTTGTAATCAA-3') were hybridized and then inserted into the NotI sites of pcDNA-RSV-Stau155-HA3 in replacement of the HA-tag. For the construction of pcDNA-RSV-Stau1DeltaNt88-Flag, the EcoRI fragment of pcDNA-RSV-Stau1DeltaNt88-HA3 that contained the mutated Stau1 sequence, was cloned into EcoRI-digested pcDNA-RSV-Stau155-Flag plasmid.
###end p 21
###begin p 22
###xml 36 39 36 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 752 755 734 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dpn</italic>
###xml 971 982 953 964 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag C15&#8211;49S</sup>
###xml 1001 1008 983 990 <sup xmlns:xlink="http://www.w3.org/1999/xlink">C15&#8211;49S</sup>
The expressors of NC-p1-YFP and Pr55Gag-YFP mutants were PCR amplified using the PCR all-around technique [59] to generate the following mutations: the C15S mutation was introduced with the primer pair 5'-AAGAGTTTCAATTGTGGCAAA-3' and 5'-GAAACTCTTAACAATCTTTCT-3'; the C49S mutation was generated with the primer pair 5'-GATAGTACTGAGAGACAGGCT-3' and 5'-AGTACTATCTTTCATTTGGTG-3'; R7S, R10S and K11S mutations (R7 mutant) were introduced with the primer pair 5'-TTTAGCAACCAAAGCTCGATTGTTAAGTGTTTC-3' and 5'-AATCGAGCTTTGGTTGCTAAAATTGCCTCTCTG-3'. PCR reactions were carried out with the Phusion enzyme (New England Biolabs) at 95degreesC for 50 s, 55degreesC for 60 s and 72degreesC for 90 s, for 18 cycles. Resulting products were incubated with 10 units of DpnI enzyme (Fermentas) and then transformed into competent bacteria. Positive clones containing the mutation(s) were screened by restriction and sequencing analyses. The double zinc fingers mutant expressors (pCMV-Pr55Gag C15-49S-YFP and pCMV-NC-p1C15-49S-YFP) were generated by PCR with the oligonucleotide primer pair for the C49S mutation using the corresponding plasmids that contain the C15S mutation.
###end p 22
###begin title 23
Membrane flotation assays and S100-P100 fractionation
###end title 23
###begin p 24
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 630 632 630 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 845 850 <span type="species:ncbi:10090">mouse</span>
Forty hours post-transfection, cell extracts were prepared by passing the cells 20 times through a 23G1 syringe in TE (10 mM Tris pH7.4, 1 mM EDTA pH 8) containing 10% sucrose and proteases inhibitors (Roche). Nuclei were removed by centrifugation at 1,000 x g. Resulting cytoplasmic extracts were separated using the membrane flotation assay as previously described [51]. Membrane-associated complexes were collected (fractions 2 and 3). Membranes were solubilized by treating these complexes with 0.5% Triton X-100 at room temperature for 5 minutes and samples were subjected to S100/P100 fractionation as previously described [51] by ultracentrifugation at 100,000 x g for 1 h at 4degreesC. Supernatants (S100 fractions) and pellets (P100 fractions) were collected and analyzed by Western blotting using anti-CA, anti-HA and anti-Na-K ATPase mouse antibodies.
###end p 24
###begin title 25
BRET assays
###end title 25
###begin p 26
###xml 74 75 74 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 196 197 195 196 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 346 348 344 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 406 408 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 409 411 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 495 496 489 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 712 713 706 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1094 1095 1088 1089 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1156 1157 1150 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1299 1300 1293 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1358 1359 1352 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1387 1391 1381 1385 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1499 1503 1493 1497 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1539 1542 1533 1536 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 1547 1551 1541 1545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1645 1646 1639 1640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
293T cells were transfected in 6-well plates with constant amounts of the Rluc-fused energy donor expressor (25-75 ng), increasing amounts of YFP-fused acceptor expressor (0.25-2 mug) and Stau1-HA3-expressing plasmid (1-1.5 mug) when indicated. 48 hours post-transfection, cells were collected in PBS-EDTA 5 mM and diluted to approximately 2 x 106 cells/mL. BRET assays were performed as described before [51,52] using a Fusion alpha-FP apparatus (Perkin-Elmer). In this interaction assay, an X-Rluc fusion protein is used as an energy donour whereas a Y-YFP fusion protein is an energy acceptor. When the two fusion proteins are in close proximity (< 100A), non-radiative resonance energy is transferred from X-Rluc to Y-YFP which in turn emits measurable fluorescence. This can be quantified by the calculation of the BRET ratio which allows detection of protein-protein interactions. The BRET ratio was defined as [(emission at 510 to 590 nm)-(emission at 440 to 500 nm) x Cf]/(emission at 440 to 500 nm), where Cf corresponds to (emission at 510 to 590 nm)/(emission at 440 to 500 nm) when Rluc fused protein is expressed alone. The total YFP activity/Rluc activity ratio reflects the relative levels of the two fusion proteins in the cells. The BRET ratio increases with the total YFP activity/Rluc activity ratio since more YFP-fused molecules bind to Rluc-fused proteins. For Pr55Gag multimerization assays, in order to avoid misinterpretation due to variations in relative levels of the Pr55Gag fusion proteins, changes in the Pr55Gag/Pr55Gag BRET ratios following Stau1 overexpression were always analyzed at similar total YFP activity/Rluc activity ratio.
###end p 26
###begin p 27
###xml 9 12 9 12 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 17 21 17 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 89 90 89 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
When Pr55Gag/Pr55Gag BRET assays were performed following membrane flotation assays, the Rluc substrate coelenterazine H (NanoLight Technology) was added to 90 muL of each fraction and BRET ratio was determined as in live cells. BRET ratios in fractions 1, 3, 4, 5 and 6 were not considered because luciferase activity was too low in these fractions and hence, did not lead to the determination of a reliable BRET ratio.
###end p 27
###begin p 28
###xml 16 17 16 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 40 42 40 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 43 44 43 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 141 142 141 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
For CA-p2-NC-p1-Rluc/Stau1-YFP and Stau155-Rluc/NC-p1-YFP interaction assays, BRET ratios were always compared at similar total YFP activity/Rluc activity ratio. The BRET ratio determined in the context of the expression of the unfused YFP protein (YFP) corresponds to non specific interactions between the energy donor and the YFP. Hence, this background BRET ratio was always subtracted from all BRET ratios and was set to 0%. The BRET ratio determined following co-expression of the energy donor and the wild type energy acceptor was set to 100%.
###end p 28
###begin p 29
###xml 22 25 22 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 30 34 30 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 106 109 106 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 110 111 110 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 128 131 128 131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 193 195 192 194 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
For dose-response Pr55Gag/Pr55Gag BRET assays, 293T cells were transfected with fixed amounts of pCMV-Pr55Gag-Rluc and pCMV-Pr55Gag-YFP and increasing amounts (0.25-2 mug) of different Stau1-HA3 expressors. BRET assays were performed 48 hours post-transfection as described above.
###end p 29
###begin title 30
Co-immunoprecipitation assays
###end title 30
###begin p 31
###xml 38 40 38 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 755 760 <span type="species:ncbi:10090">mouse</span>
293T cells were transfected with Stau155-flag and Gag expressors using Lipofectamine 2000 (Invitrogen). Twenty hours post-transfection, cells were collected in lysis buffer (150 mM NaCl, 50 mM Tris pH 7.4, 1 mM EDTA, 1% Triton X-100) containing proteases inhibitors (Roche). Each cell lysate (1.5 mg of proteins) was pre-cleared with IgG-agarose (Sigma-Aldrich) for 1 h at 4degreesC and then subjected to immunoprecipitation using 15 muL of anti-Flag M2 affinity gel (Sigma-Aldrich) for 2 h at 4degreesC. Immune complexes were washed 3 times during 5 minutes with cold lysis buffer, eluted with the Flag peptide (Sigma-Aldrich), resolved in SDS-containing acrylamide gels and analyzed for their content in Stau1 and Gag proteins by Western blotting using mouse monoclonal anti-Flag (Sigma-Aldrich), anti-GFP (Roche) and anti-CA antibodies.
###end p 31
###begin title 32
Virus-like particle purification
###end title 32
###begin p 33
###xml 38 40 38 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 43 45 43 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 431 435 430 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
293T cells were transfected with Stau155-HA3 and Gag expressors using Lipofectamine 2000 (Invitrogen). Twenty hours post-transfection, supernatants were collected and cleared through a 0.45 mum filter. VLPs were pelleted through a sucrose cushion (20% in Tris-NaCl buffer) by ultracentrifugation during 1 hour at 220,000 x g. VLPs were resuspended in Tris-NaCl buffer and analyzed by Western blotting using anti-CA antibodies. Pr55Gag signals in the VLPs and the cell extracts were quantitated using the Quantity One (version 4.5) software (Bio-Rad).
###end p 33
###begin title 34
Results
###end title 34
###begin title 35
###xml 39 43 39 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
Both NC zinc fingers mediate Stau1/Pr55Gag interaction
###end title 35
###begin p 36
###xml 38 42 38 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 233 238 233 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F135A</sup>
###xml 292 296 292 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 390 394 390 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 660 663 660 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 713 715 713 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 716 717 716 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 909 913 909 913 <sup xmlns:xlink="http://www.w3.org/1999/xlink">C15S</sup>
###xml 937 941 937 941 <sup xmlns:xlink="http://www.w3.org/1999/xlink">C49S</sup>
###xml 975 982 975 982 <sup xmlns:xlink="http://www.w3.org/1999/xlink">C15&#8211;49S</sup>
###xml 1026 1028 1026 1028 <sup xmlns:xlink="http://www.w3.org/1999/xlink">R7</sup>
###xml 1037 1039 1037 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1062 1063 1062 1063 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7</sup>
###xml 1068 1071 1068 1071 <sup xmlns:xlink="http://www.w3.org/1999/xlink">10 </sup>
###xml 1078 1081 1078 1081 <sup xmlns:xlink="http://www.w3.org/1999/xlink">11 </sup>
###xml 1118 1120 1118 1120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1214 1216 1214 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1414 1416 1414 1416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 1563 1570 1563 1570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">C15&#8211;49S</sup>
###xml 97 102 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 331 336 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 488 493 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 590 595 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1198 1203 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The interaction between Stau1 and Pr55Gag is likely a critical determinant for Stau1 function in HIV-1 assembly. Indeed we previously showed that a single point mutation in the third double-stranded RNA-binding domain of Stau1 (Stau1F135A) prevented both the association of the mutant to Pr55Gag and the Stau1-mediated increase of HIV-1 assembly [51-53]. Moreover, we showed that Stau1/Pr55Gag interaction required the NC domain [52] that contains motifs involved in several steps during HIV-1 assembly. As a first step, to understand the molecular mechanisms underlying Stau1 influence on HIV-1 assembly, we identified which NC sub-domain is required for Pr55Gag/Stau1 association using the BRET assay with Stau155-Rluc and wild type or mutant NC-p1-YFP fusion proteins. Four NC mutants were constructed. Point mutations were introduced in the NC-p1-YFP fusion protein to disrupt the first zinc finger (NC-p1C15S-YFP), the second (NC-p1C49S-YFP), both zinc fingers (NCp1-YFPC15-49S) or the N-terminal basic residues (NCp1-YFPR7)(Figure 1A). For this mutant, Arg7, Arg10 and Lys11 were substituted for serines (Figure 1A). Mutations in this basic region were previously reported to severely affect HIV-1 assembly [24]. Constructs encoding the wild type and mutants NC fusion proteins were transfected in 293T cells and their expression patterns were analyzed by Western blotting using an anti-GFP antibody. Figure 1B shows that wild type and mutant NC-p1-YFP proteins were well expressed and have the expected molecular weight. However, for unknown reasons, NC-p1C15-49S-YFP was always slightly less expressed than the other NC-p1-YFP proteins.
###end p 36
###begin p 37
###xml 0 85 0 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Design and expression of NC mutants used for the fine mapping of Stau1/NC interaction</bold>
###xml 87 91 87 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 123 127 123 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 326 330 326 330 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
Design and expression of NC mutants used for the fine mapping of Stau1/NC interaction. (A) Schematic representation of Pr55Gag with emphasis on the sequence of NC and its two zinc fingers. Several point mutations were introduced in the basic region or in the zinc fingers of NC-p1-YFP fusion protein to generate four mutants. (B) 293T cells were transfected with YFP, NC-p1-YFP and mutated NC-p1-YFP expressors. 48 hours post-transfection, cell lysates were prepared and analyzed by Western blotting using anti (alpha)-GFP antibodies.
###end p 37
###begin p 38
###xml 73 76 73 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55 </sup>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 214 215 214 215 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 445 446 443 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 673 675 671 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 676 677 674 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 809 814 807 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A, B</xref>
###xml 952 953 950 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 972 974 970 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1063 1065 1061 1063 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1066 1067 1064 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1106 1108 1104 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1147 1149 1145 1147 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1150 1151 1148 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1178 1183 1176 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A, B</xref>
###xml 1325 1327 1323 1325 <sup xmlns:xlink="http://www.w3.org/1999/xlink">R7</sup>
###xml 1408 1413 1406 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A, B</xref>
###xml 1474 1481 1472 1479 <sup xmlns:xlink="http://www.w3.org/1999/xlink">C15&#8211;49S</sup>
###xml 1616 1618 1614 1616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 1670 1671 1668 1669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1736 1738 1734 1736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 1765 1772 1763 1770 <sup xmlns:xlink="http://www.w3.org/1999/xlink">C15&#8211;49S</sup>
###xml 1878 1882 1876 1880 <sup xmlns:xlink="http://www.w3.org/1999/xlink">C15S</sup>
###xml 1896 1900 1894 1898 <sup xmlns:xlink="http://www.w3.org/1999/xlink">C49S</sup>
###xml 2007 2012 2005 2010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A, B</xref>
These proteins were then tested for their capacity to interact with Stau155 using the BRET assay in live 293T cells (Figure 2A). This technique allows us to detect protein-protein interaction in live cells between Rluc-fused Stau1 and NC-p1-YFP molecules (Figure 2A). Indeed, when the two fusion proteins are in close proximity (</= 100A) as a consequence of Stau1-NC interaction, non-radiative resonance energy is transferred from the emitting Rluc to YFP which becomes excited and in turn emits fluorescence. A BRET ratio is calculated for each condition (see Methods). To perform BRET saturation experiments, we transfected 293T cells with constant amounts of pCMV-Stau155-Rluc plasmid and increasing amount of different NC-p1-YFP expressors. BRET assays were performed 48 hours post-transfection (Figures 2A, B). BRET saturation experiments allowed us to compare BRET ratios at the same relative ratio between fusion proteins (comparable total YFP/Rluc ratio) (Figure 2B). As expected, we readily detected a specific BRET between wild type NC-p1-YFP and Stau155-Rluc (arbitrarily set to 100% in Figure 2B) as compared to co-expression of Stau155-Rluc and YFP alone (Figures 2A, B). Mutations that modify the NC N-terminal basic region did not affect the binding of NC to Stau1 since the saturation profile for Stau1/NC-p1R7-YFP BRET was almost identical to the one obtained with Stau1/NC-p1-YFP (Figures 2A, B). In contrast, when the two zinc fingers were mutated (NC-p1C15-49S-YFP), the BRET saturation profile was comparable to that obtained with YFP alone and hence, mostly attributable to background (Figure 2A). When compared to NC-p1-YFP at the same total YFP/Rluc ratio, the corrected BRET ratio was decreased by 80% (Figure 2B). This suggests that NC-p1C15-49S-YFP lost almost completely its ability to interact with Stau1. Mutations in individual zinc finger (NC-p1C15S-YFP and NC-p1C49S-YFP) only affected the BRET ratio by 30-40% and these two mutants showed an intermediate profile (Figures 2A, B).
###end p 38
###begin p 39
###xml 38 42 38 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 0 53 0 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The NC zinc fingers mediate Stau1/Pr55<sup>Gag </sup>interaction</bold>
###xml 55 59 55 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 191 193 191 193 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 194 195 194 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 381 382 381 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 553 557 553 557 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 606 607 606 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 708 710 708 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 711 712 711 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 779 781 779 781 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 782 783 782 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 919 923 919 923 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 960 963 960 963 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 975 986 975 986 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag C15-49S</sup>
###xml 1104 1108 1104 1108 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) </bold>
###xml 1123 1125 1123 1125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1160 1163 1160 1163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
The NC zinc fingers mediate Stau1/Pr55Gag interaction. (A) Top: schematic representation of the Stau1/NC-p1 BRET assay. Bottom: 293T cells were transfected with constant amounts of pCMV-Stau155-Rluc and increasing amounts of wild type or mutated NC-p1-YFP expressors. 48 hours post-transfection, BRET ratios were determined and plotted in function of their corresponding total YFP/Rluc ratio which allows us to compare BRET ratios at the same relative expression levels of fusion proteins. This figure is representative of four independent experiments. (B) BRET ratios were compared at identical total YFP/Rluc ratio and corrected by subtracting the background BRET ratio calculated for unfused YFP and Stau155-Rluc co-expression (see Methods). The corrected BRET ratio for Stau155-Rluc and wild type NC-p1-YFP coexpression was arbitrarily set to 100%. These results are representative of four independent experiments. (C) 293T cells were transfected with Pr55Gag-YFP or Pr55Gag C15-49S-YFP expressors. Twenty hours post-transfection, lysates were analyzed by Western blotting using anti-GFP antibodies. (D) Following Stau155-Flag and wild-type or mutated Pr55Gag-YFP co-expression, 293T cell lysates were submitted to immunoprecipitation using anti-Flag antibodies. Immune complexes were analyzed for their content of YFP-fused proteins and Stau1-Flag using anti (alpha)-GFP and anti (alpha)-Flag antibodies, respectively. Anti (alpha)-GAPDH antibodies were used as loading controls. This figure is representative of four independent experiments.
###end p 39
###begin p 40
This suggests that the integrity of at least one NC zinc fingers is required for Stau1/NC interaction.
###end p 40
###begin p 41
###xml 133 136 133 136 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 157 160 157 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 229 240 229 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag C15&#8211;49S</sup>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 346 349 346 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 488 491 488 491 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55 </sup>
###xml 521 524 521 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 574 576 574 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 767 769 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 802 805 802 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 849 851 849 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 928 930 928 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 954 965 954 965 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag C15&#8211;49S</sup>
###xml 1029 1031 1029 1031 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1070 1072 1070 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 1148 1151 1148 1151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55 </sup>
###xml 1168 1176 1168 1176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag C15S</sup>
###xml 1189 1197 1189 1197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag C49S</sup>
###xml 1246 1248 1246 1248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1326 1330 1326 1330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1460 1464 1460 1464 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
We used a second technique to confirm the involvement of both zinc fingers in Stau1-NC interaction in the context of full-length Pr55Gag. We generated a Pr55Gag-YFP-expressing plasmid in which both zinc fingers were mutated (Pr55Gag C15-49S-YFP)(see below). As shown in Figure 2C, this mutant was expressed to the same level as the wild-type Pr55Gag-YFP and migrated in SDS-containing acrylamide gels at the expected molecular weight (80 kDa). Following co-expression of Flag-tagged Stau155 with wild type or mutated Pr55Gag-YFP in 293T cells (Figure 2D, upper panel), Stau155-Flag-containing complexes were immunoprecipitated using anti-Flag antibodies. Immunopurified material was analyzed by Western blot using monoclonal anti-GFP and anti-Flag antibodies (Figure 2D, lower panel). As expected, Pr55Gag-YFP successfully co-precipitated with Stau155-Flag. In contrast, despite similar levels of expression in the cell (Figure 2D, upper panel), the Pr55Gag C15-49S-YFP mutant was not efficiently co-immunoprecipitated with Stau155-Flag as compared to wild type (Figure 2D, lower panel) suggesting that the association between this mutant and Stau155 is impaired. Pr55Gag C15S-YFP and Pr55Gag C49S-YFP mutants retained some association with Stau155-Flag although they displayed lower binding capability than the wild type Pr55Gag (not shown), consistent with the BRET assay. Altogether, these results show that the two zinc fingers within the NC domain of Pr55Gag mediate its association with Stau1. Moreover, this suggests that Stau1 influences those assembly processes that depend on NC zinc fingers.
###end p 41
###begin title 42
###xml 58 62 58 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
Mutations in the NC zinc fingers severely compromises Pr55Gag multimerization and release
###end title 42
###begin p 43
###xml 41 45 41 45 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 203 205 203 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 206 208 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 337 341 337 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 380 384 380 384 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 456 459 456 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 472 483 472 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag C15&#8211;49S</sup>
###xml 507 509 507 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 642 645 642 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 658 669 658 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag C15&#8211;49S</sup>
###xml 713 715 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 762 773 762 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag C15&#8211;49S</sup>
###xml 872 875 872 875 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 888 890 888 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 998 1009 998 1009 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WM184&#8211;185AA</sup>
###xml 1022 1024 1022 1024 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 1033 1037 1033 1037 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1134 1136 1134 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1137 1139 1137 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 1235 1238 1235 1238 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 1251 1262 1251 1262 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag C15&#8211;49S</sup>
###xml 1287 1289 1287 1289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 31 36 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 187 192 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The fact that Stau1 influences HIV-1 Pr55Gag multimerization and associates with NC zinc fingers is consistent with previous reports showing that these structural motifs are important in HIV-1 assembly [29,30,46]. To confirm this hypothesis in a system that tests direct interaction, we evaluated the consequence of mutations in the Pr55Gag zinc fingers on VLP release and on Pr55Gag dimerization using the BRET assay. 293T cells were transfected with Pr55Gag-YFP and Pr55Gag C15-49S-YFP expressors (Figure 3A). Twenty-four hours post-transfection, VLPs were collected from the supernatant and cells were collected. In the cell extracts, Pr55Gag-YFP and Pr55Gag C15-49S-YFP were present at similar levels (Figure 3B, left panel). In contrast, the release of Pr55Gag C15-49S-YFP in the cell supernatant was reduced by 95.1% (+/- 3.4 S.D.; n = 3) as compared to that of Pr55Gag-YFP (Figure 3B, right panel) suggesting that this mutant failed to efficiently assemble. Used as a negative control, MA-CAWM184-185AA-YFP (Figure 3A), a Pr55Gag mutant that was shown to be almost completely monomeric in the cell and unable to generate VLPs [26,51], was not detected in the cell supernatant although it was expressed at higher levels than Pr55Gag-YFP and Pr55Gag C15-49S-YFP in the cell (Figure 3B).
###end p 43
###begin p 44
###xml 23 27 23 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Disruption of both Pr55<sup>Gag </sup>zinc fingers affects VLP production</bold>
###xml 64 68 64 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 157 161 157 161 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 517 521 509 513 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 583 586 575 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 587 588 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 820 821 812 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
Disruption of both Pr55Gag zinc fingers affects VLP production. (A) Schematic representation of the Gag fusion proteins used in the BRET and release assays. (B) Wild-type or mutated YFP-fused Gag proteins were expressed in 293T cells for twenty-four hours. VLPs in the cell supernatant were purified. Cell lysates and VLPs were analyzed by Western blotting using anti (alpha)-GFP antibodies. Anti (alpha)-GAPDH antibodies were used as loading controls. This figure is representative of three independent experiments. (C) 293T cells were transfected with constant amounts of pCMV-Pr55Gag-Rluc and increasing amounts of wild type or mutated YFP-fused Gag expressors. Twenty-four hours post-transfection, cells were collected and BRET ratios determined. BRET ratios are plotted in function of their corresponding total YFP/Rluc ratio. This figure is representative of three independent experiments.
###end p 44
###begin p 45
###xml 69 72 69 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 155 166 155 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag C15&#8211;49S</sup>
###xml 192 195 192 195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 196 197 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 220 223 220 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 290 294 290 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 393 404 393 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag C15&#8211;49S</sup>
###xml 437 440 437 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 441 442 441 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 558 569 558 569 <sup xmlns:xlink="http://www.w3.org/1999/xlink">WM184&#8211;185AA</sup>
###xml 656 660 656 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 866 871 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Then, we determined whether mutations in the zinc fingers affect Pr55Gagmultimerization. Using the BRET assay in live cells, we tested the capacity of Pr55Gag C15-49S-YFP to dimerize with Pr55Gag-Rluc, the wild-type Pr55Gag-YFP being used as control (Figure 3A). As shown in Figure 3C, Pr55Gag homo-dimerization was readily detectable with a BRET ratio of 0.09 at saturation. In contrast, Pr55Gag C15-49S-YFP failed to interact with Pr55Gag-Rluc in the BRET assay since its saturation curve was similar to the one obtained with the monomeric Gag mutant MA-CAWM184-185AA-YFP. Altogether, these results clearly show that, in the context of VLP assembly, Pr55Gag zinc fingers are important for multimerization and release. This suggests that Stau1, through its binding to the NC zinc fingers could influence crucial processes that are controlled by these motifs during HIV-1 assembly.
###end p 45
###begin title 46
###xml 85 89 85 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
The N-terminal domain of Stau1 is required for the Stau1-mediated enhancement of Pr55Gag multimerization
###end title 46
###begin p 47
###xml 85 89 85 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 171 175 171 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 408 411 408 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 416 420 416 420 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 481 485 481 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 509 511 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 513 515 513 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 526 527 526 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 550 554 550 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 638 642 638 642 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 733 737 733 737 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 830 832 830 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 835 837 835 837 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 863 866 863 866 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 867 868 867 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 880 883 880 883 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 911 914 911 914 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 919 923 919 923 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 977 981 977 981 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1006 1008 1006 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 1010 1012 1010 1012 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 1107 1110 1107 1110 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 1115 1119 1115 1119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1145 1149 1145 1149 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1186 1195 1186 1191 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 1198 1199 1194 1195 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1312 1314 1308 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 1361 1364 1357 1360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 1369 1373 1365 1369 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1461 1463 1457 1459 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1466 1468 1462 1464 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1520 1525 1516 1521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B, D</xref>
###xml 1567 1577 1563 1569 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88 </sup>
###xml 1641 1643 1633 1635 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1651 1653 1643 1645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 1697 1701 1689 1693 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1736 1746 1728 1734 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88 </sup>
###xml 1799 1803 1787 1791 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1866 1868 1854 1856 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1871 1873 1859 1861 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1992 1995 1980 1983 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 2000 2004 1988 1992 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 2063 2065 2051 2053 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 2068 2070 2056 2058 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 2105 2110 2093 2098 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F135A</sup>
###xml 2113 2114 2101 2102 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 2154 2157 2142 2145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 2183 2187 2171 2175 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 2220 2222 2208 2210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 2274 2278 2262 2266 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
We previously showed that Stau1 over-expression or depletion from cells enhanced Pr55Gag multimerization. To determine if the binding of Stau1 to NC is sufficient for Pr55Gag multimerization or whether other determinants within Stau1 are required for this process, we tested several Stau1 deletion mutants for their capacity to enhance assembly (Figure 4A). To this end, we used the previously described Pr55Gag/Pr55Gag BRET assay in live 293T cells as a sensor for changes in Pr55Gag multimerization (Figure 4B)[51]. Indeed, Rluc- and YFP-fused Pr55Gag co-expression generates a positive BRET ratio in live cells as a consequence of Pr55Gag multimerization. In order to compare BRET ratio changes at the same relative levels of Pr55Gag fusion proteins, we performed BRET saturation experiments. As previously reported, when Stau155-HA3 was co-expressed with Pr55Gag-Rluc and Pr55Gag-YFP in 293T cells, the Pr55Gag/Pr55Gag BRET ratio increased as a consequence of enhanced Pr55Gag multimerization (Figures 4B)[51]. Several HA-tagged Stau1 deletion mutants were then tested for their capacity to enhance Pr55Gag/Pr55Gag BRET ratio and hence, Pr55Gag multimerization. Interestingly, Stau1DeltaNt88-HA3, a mutant that lacks the dsRBD2 as a consequence of the deletion of the first N-terminal 88 amino acids (Figure 4A) was unable to significantly increase the Pr55Gag/Pr55Gag BRET ratio in live cells [1.29 (+/-0.13 S.D. n = 4)-fold induction] as compared to Stau155-HA3 [2.04 (+/-0.09 S.D. n = 4)-fold induction] (Figures 4B, D). Western blot analyses showed that Stau1DeltaNt88 was expressed at levels comparable to that of wild type Stau1-HA3 (Figure 4C). Nevertheless, a moderate increase in Pr55Gag multimerization was seen when Stau1DeltaNt88 was highly over-expressed although its effect on Pr55Gag multimerization was always weaker than that obtained with Stau155-HA3 (see below). In contrast, mutants with deletion in dsRBD4, dsRBD5 or tubulin-binding domain (TBD) all enhanced the Pr55Gag/Pr55Gag BRET ratio at levels comparable to that obtained with Stau155-HA3 (data not shown). As control, Stau1F135A-HA3, a Stau1 mutant that does not bind Pr55Gag, failed to stimulate Pr55Gag multimerization (data not shown)[51]. Therefore, the Stau1-mediated enhancement of Pr55Gag multimerization requires two determinants: dsRBD3 for the association with NC and the N-terminus.
###end p 47
###begin p 48
###xml 62 66 62 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 0 95 0 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The N-terminus of Stau1 is required for the modulation of Pr55<sup>Gag </sup>multimerization in live cells</bold>
###xml 97 101 97 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 144 147 144 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55 </sup>
###xml 297 301 297 301 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 337 340 337 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 345 349 345 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 399 403 399 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 482 485 482 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 486 487 486 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 526 529 526 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 588 590 588 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 593 595 593 595 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 603 612 603 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 615 617 611 613 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 661 662 657 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 807 808 803 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 903 907 899 903 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 987 991 983 987 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 1280 1284 1272 1276 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) </bold>
###xml 1334 1335 1326 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1386 1390 1378 1382 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
The N-terminus of Stau1 is required for the modulation of Pr55Gag multimerization in live cells. (A) Schematic representation of HA-tagged Stau155 expressors. Stau1 double-stranded RNA-binding domains (dsRBD) and tubulin-binding domain (TBD) are represented as grey and black boxes, respectively. (B) Schematic representation of the Pr55Gag/Pr55Gag BRET assay. This assay is used as a sensor of Pr55Gag multimerization. 293T cells were transfected with constant amounts of pCMV-Pr55Gag-Rluc and increasing amounts of pCMV-Pr55Gag-YFP. A constant amount of a third plasmid expressing Stau155-HA3 or Stau1DeltaNt88-HA3 was included in the transfection procedure. Rluc activity as well as transmitted and total YFP activities was measured. BRET ratios were plotted in function of their corresponding total YFP/Rluc ratio which allows us to compare BRET ratios at the same relative expression levels of Pr55Gag fusion proteins. This figure is representative of four independent experiments. (C) Cells corresponding to the four last points of each curve from Figure 4B were lysed. Cell lysates were analyzed by Western blotting using anti (alpha)-HA antibodies for their content in over-expressed Stau1 proteins. *: Non-specific labelling typically obtained with the anti-HA antibody. (D) BRET ratios were compared at comparable total YFP/Rluc ratio. The BRET ratio corresponding to the pr55Gag fusions expressed alone was arbitrarily set to 1. The BRET induction levels were then determined and are shown in the graph. These results are representative of 4 experiments.
###end p 48
###begin title 49
###xml 5 15 5 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88 </sup>
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Stau1DeltaNt88 still interacts with HIV-1 Gag
###end title 49
###begin p 50
###xml 28 38 28 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88 </sup>
###xml 59 62 55 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 102 111 98 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 136 140 128 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 153 154 145 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 277 281 269 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 282 284 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 298 300 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 354 363 346 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 377 379 365 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 407 409 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 463 465 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 494 496 482 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 515 524 503 508 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 570 579 554 559 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 622 625 602 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 701 712 681 688 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;dsRBD3</sup>
###xml 791 793 767 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 852 861 828 833 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 882 883 854 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 946 949 918 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55 </sup>
###xml 1008 1010 980 982 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1036 1037 1008 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 1101 1106 1073 1078 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F135A</sup>
###xml 1112 1114 1084 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 1167 1170 1139 1142 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55 </sup>
To test the ability of Stau1DeltaNt88 to interact with Pr55Gag, we performed BRET assays between Stau1DeltaNt88-YFP and a truncated Pr55Gag (CA-p2-NC-p1-Rluc) that was previously shown by the co-immunoprecipitaton assay to interact as efficiently with Stau1 as full-length Pr55Gag [52] and (Figure 5A). To verify efficiency between these molecules, Stau1DeltaNt88-YFP and Stau155-YFP were expressed (Figure 5B) and the BRET saturation profiles determined (Figure 5C). Curves obtained with Stau155-YFP and with Stau1DeltaNt88-YFP were almost similar suggesting that Stau1DeltaNt88mutant retains its capacity to bind to Pr55Gag. The BRET ratios were specific since the Gag-binding deficient mutant Stau1DeltadsRBD3-YFP showed reduced BRET ratios. In independent saturation experiments (Figure 5D), the specific BRET ratio following co-expression of Stau1DeltaNt88-YFP and CA-p2-NC-p1-Rluc was comparable [105.7 (+/- 18.1 S.D.)% of CA-p2-NC-p1/Stau155 corrected BRET ratio] to that obtained with wild type Stau155-YFP at similar total YFP/Rluc ratio. We could not detect a specific BRET signal when Stau1F135A-YFP [52] was used [1.3 (+/- 22.1 S.D.)% of CA-p2-NC-p1/Stau155 corrected BRET ratio].
###end p 50
###begin p 51
###xml 5 15 5 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88 </sup>
###xml 0 53 0 49 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Stau1<sup>&#916;Nt88 </sup>interacts with HIV-1 Gag in live cells</bold>
###xml 55 59 51 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 121 125 117 121 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 176 177 172 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 240 242 236 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 256 265 252 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 361 365 349 353 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 703 704 691 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 722 726 710 714 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) </bold>
###xml 775 776 763 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 884 885 872 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 949 950 937 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 963 965 951 953 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1006 1010 994 998 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(E) </bold>
###xml 1050 1054 1038 1042 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 30 35 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 160 163 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Stau1DeltaNt88 interacts with HIV-1 Gag in live cells. (A) Schematic representation of the Stau1/CA-p2-NC-p1 BRET assay. (B) 293T cells were cotransfected with CMV-CA-p2-NC-p1-Rluc and Stau1-YFP expressors. 48 hours post-transfection, Stau155-YFP and Stau1DeltaNt88-YFP contents in the cells were analyzed by Western blotting using anti (alpha)-GFP antibodies. (C) 293T cells were transfected with constant amounts of CA-p2-NC-p1-Rluc-expressing plasmid and increasing amounts of wild-type or mutated YFP-fused Stau1 expressors. Twenty four hours post-transfection, live transfected cells were used for CA-p2-NC-p1/Stau1 BRET assays. BRET ratios are plotted in function of their corresponding total YFP/Rluc ratio. n = 4. (D) BRET ratios were compared at identical total YFP/Rluc ratio and corrected by subtracting the background BRET ratio calculated for unfused YFP and CA-p2-NC-p1-Rluc co-expression. The corrected BRET ratio between CA-p2-NC-p1-Rluc and Stau155-YFP was arbitrarily set to 100%. n = 4. (E) 293T cells were co-transfected with Pr55Gag and wild-type or N-terminally truncated Stau1-Flag expressors. Twenty-four hours post-transfection, cell extracts were prepared and subjected to immunoprecipitation using anti-Flag antibodies. Cell lysates and immune complexes were analyzed by Western blotting using anti (alpha)-Flag and anti (alpha)-CA antibodies. Anti (alpha)-GAPDH antibodies were used as a loading control. n = 2.
###end p 51
###begin p 52
###xml 20 30 20 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88 </sup>
###xml 52 56 48 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 111 113 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5E</xref>
###xml 120 124 116 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 154 164 150 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88 </sup>
###xml 204 206 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5E</xref>
###xml 366 370 358 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 435 437 427 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 452 461 444 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 475 477 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5E</xref>
###xml 532 542 520 526 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88 </sup>
###xml 569 573 553 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 615 619 599 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 686 690 670 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 721 726 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The ability of Stau1DeltaNt88 to associate with Pr55Gag was confirmed in co-immunoprecipitation assays (Figure 5E). Pr55Gag and flag-tagged Stau1 or Stau1DeltaNt88 were co-expressed in 293T cells (Figure 5E, left panel) and proteins in the cell extracts were immunoprecipitated using anti-flag antibody. Western blot analyses of the immune complexes showed that Pr55Gag successfully co-precipitated in a specific manner with both Stau155-flag and Stau1DeltaNt88-FLAG (Figure 5E, right panel). These results show that, although Stau1DeltaNt88 is unable to stimulate Pr55Gag multimerization, its interaction with Pr55Gag was maintained. This result suggests that Stau1 association to Pr55Gag is not sufficient to influence HIV-1 assembly and that Stau1 N-terminus contains a regulatory element that is important for its function during this process.
###end p 52
###begin title 53
###xml 5 14 5 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 17 19 13 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 76 80 72 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
Stau1DeltaNt88-HA3 does not enhance the assembly of membrane-associated Pr55Gag complexes
###end title 53
###begin p 54
###xml 64 68 64 68 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 117 119 117 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 154 163 154 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 166 168 162 164 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 267 276 263 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 279 281 271 273 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 365 374 357 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 377 379 365 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 387 389 375 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 392 394 380 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 514 516 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 518 520 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 706 715 694 699 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 718 720 702 704 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 796 798 780 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 801 803 785 787 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 846 848 830 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 855 858 839 842 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 863 867 847 851 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1056 1058 1040 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 1060 1062 1044 1046 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1063 1065 1047 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 1066 1068 1050 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 1106 1108 1090 1092 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1111 1113 1095 1097 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1171 1174 1155 1158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 1179 1183 1163 1167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1254 1256 1238 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 1318 1322 1302 1306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1383 1392 1367 1372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 1395 1397 1375 1377 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1004 1009 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We previously showed that the Stau1-mediated enhancement of Pr55Gag multimerization occurs in membrane compartments [51]. Therefore, to test whether Stau1DeltaNt88-HA3 reaches the membranes and whether the whole cell analysis described above masked an effect of Stau1DeltaNt88-HA3 on assembly, membrane-associated virus assembly was analyzed in the context of Stau1DeltaNt88-HA3 or Stau155-HA3 over-expression. Cytoplasmic extracts from transfected 293T cells were analyzed by the membrane flotation assay (Figure 6A)[51]. This assay allows the separation of membrane-associated complexes (fraction 2; M) from the cytosolic ones (fractions 7, 8 and 9; Cy). First, Western blot analysis indicated that Stau1DeltaNt88-HA3 was both over-expressed and present in membranes at the same levels as Stau155-HA3 (data not shown). As previously described [51], Pr55Gag/Pr55Gag BRET was readily detected in the membrane fraction (BRET ratio of 0.33) but not in the cytosolic fractions consistent with the fact that HIV-1 assembly occurs on cellular membranes (Figure 6B)[10,61,62]. Moreover, as reported before, Stau155-HA3 over-expression led to an increase of 1.6-fold in the Pr55Gag/Pr55Gag BRET ratio in the membrane fraction but not in the cytosolic fraction [51]. In contrast, there was little change in the ability of Pr55Gag to multimerize in the membrane fraction when the mutant Stau1DeltaNt88-HA3 was over-expressed.
###end p 54
###begin p 55
###xml 5 14 5 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 17 19 13 15 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 82 85 78 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 0 85 0 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Stau1<sup>&#916;Nt88</sup>-HA<sub>3 </sub>does not affect the multimerization of membrane-associated Pr55<sup>Gag</sup></bold>
###xml 87 91 83 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 184 187 180 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 188 189 184 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 198 201 194 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 218 220 214 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 342 346 338 342 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 350 353 346 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 358 362 354 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 479 480 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 558 562 554 558 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 681 683 677 679 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1031 1035 1027 1031 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) </bold>
Stau1DeltaNt88-HA3 does not affect the multimerization of membrane-associated Pr55Gag. (A) Schematic representation of the experimental procedure. 293T cells were transfected with Pr55Gag-Rluc, Pr55Gag-YFP and Stau1-HA3 expressors. 48 hours post-transfection, cytoplasmic extracts were prepared and subjected to the membrane flotation assay. (B) Pr55Gag/Pr55Gag BRET ratio was determined in each collected fraction. BRET ratios in fractions 1, 3, 4, 5 and 6 were omitted because Rluc activity in these fractions was too low to provide a reliable BRET ratio. (C) Schematic representation of the experimental procedure. 293T cells were transfected with HxBRU PR-provirus and Stau1-HA3 expressors. 24 hours post-transfection, cytoplasmic extracts were prepared and subjected to the membrane flotation assay. Membrane fractions were collected and treated with 0.5% Triton X-100 during 5 minutes at room temperature in order to solubilize membranes. Resulting samples were subjected to ultracentrifugation at 100,000 x g during 1 hour. (D) Resulting supernatants (S100; S) and pellets (P100; P) were analyzed by Western blotting using anti (alpha)-CA, anti (alpha)-Na-K ATPase and anti (alpha)-HA antibodies. *: Non-specific labelling typically obtained with the anti-HA antibody.
###end p 55
###begin p 56
###xml 22 31 22 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 34 36 30 32 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 52 56 48 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 209 213 205 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 321 325 317 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 336 338 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 705 707 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6C</xref>
###xml 985 987 981 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 994 998 990 994 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1116 1120 1112 1116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1264 1268 1260 1264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1611 1614 1601 1604 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 1671 1673 1661 1663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
###xml 1675 1677 1665 1667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 1685 1687 1675 1677 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1690 1692 1680 1682 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1749 1753 1739 1743 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1829 1833 1819 1823 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1857 1859 1847 1849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6D</xref>
###xml 1880 1889 1870 1875 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 1892 1893 1878 1879 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1911 1916 1897 1902 <sup xmlns:xlink="http://www.w3.org/1999/xlink">F135A</sup>
###xml 1919 1921 1905 1907 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1938 1940 1924 1926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 1941 1943 1927 1929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 1983 1987 1969 1973 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 2123 2127 2109 2113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 131 136 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 2143 2148 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The inability of Stau1DeltaNt88-HA3 to modulate Pr55Gag multimerization was then tested in the context of provirus-driven immature HIV-1 production. We had previously shown that Stau1-mediated increase in Pr55Gag multimerization correlated with a partial resistance to mild detergent treatment of membrane-associated Pr55Gag complexes [51]. Stau1 expressors and the protease-defective provirus HxBRU PR-were cotransfected in 293T cells. Forty hours post-transfection, membrane flotation assays on cytoplasmic extracts were performed and fractions containing membrane-associated complexes were collected. The resulting complexes were then subjected to ultracentrifugation at 100,000 x g for 1 hour (Figure 6C). In this assay, insoluble or high-density complexes are found in the pellet (P100) whereas proteins that are soluble or components of small complexes are retained in the supernatant (S100). Resulting P100 and S100 fractions were analyzed by Western blot. As previously shown [51], Pr55Gag as well as the membrane marker, sodium potassium (Na-K) ATPase, were primarily found in the P100 fraction because Pr55Gag was membrane-associated (data not shown). This was observed whether Stau1 proteins were over-expressed or not (data not shown). To separate Pr55Gag complexes from membranes, membranes were solubilized with 0.5% Triton-X100. These experiments were done at room temperature to also solubilize lipid rafts and other membrane compartments that are detergent-resistant at 4degreesC. As reported before, membrane solubilization prior to S100/P100 fractionation resulted in a complete shift of Pr55Gagcomplexes and Na-K ATPase into the S100 fraction (Figure 6D)[51]. Stau155-HA3 overexpression led to a partial resistance of 33% of Pr55Gag complexes to Triton-X100 treatment, likely as a consequence of enhanced Pr55Gag multimerization (Figure 6D). In contrast, Stau1DeltaNt88-HA3, as well as Stau1F135A-HA3 used as control [51,52] failed to increase the density of Pr55Gag complexes. Altogether, these results support the conclusion that the N-terminus of Stau1 is required for Stau1-mediated increase of Pr55Gag assembly during HIV-1 assembly.
###end p 56
###begin title 57
###xml 29 32 29 32 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55 </sup>
###xml 70 74 70 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
Amino acids 26 to 37 of Stau155 are important for its function in Pr55Gag multimerization
###end title 57
###begin p 58
###xml 120 124 120 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 192 201 192 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt25</sup>
###xml 204 206 200 202 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 215 224 211 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt37</sup>
###xml 227 229 219 221 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 268 270 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 287 290 279 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 295 299 287 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 335 344 327 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt25</sup>
###xml 347 349 335 337 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 393 395 381 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 398 400 386 388 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 484 486 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 507 516 495 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt37</sup>
###xml 519 521 503 505 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 628 637 612 617 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 640 641 620 621 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 684 686 664 666 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 689 691 669 671 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 699 708 679 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt25</sup>
###xml 711 713 687 689 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 721 723 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
###xml 762 765 738 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 770 774 746 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 814 816 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7D</xref>
###xml 851 860 827 832 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt37</sup>
###xml 863 865 835 837 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 873 882 845 850 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 885 887 853 855 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 908 911 876 879 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 916 920 884 888 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1190 1194 1158 1162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1242 1246 1210 1214 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
To more precisely map the functional determinant within the N-terminal region that is involved in the regulation of Pr55Gag multimerization, we generated two additional deletion mutants, Stau1DeltaNt25-HA3 and Stau1DeltaNt37-HA3 and confirmed their expression (Figure 7A). Using the Pr55Gag/Pr55Gag BRET assay in live 293T cells, Stau1DeltaNt25-HA3 enhanced the BRET ratio like wild type Stau155-HA3 suggesting that the first 25 amino acids are not required for this function (Figure 7B). In contrast, Stau1DeltaNt37-HA3 did not significantly enhance the BRET ratio and generated a BRET curve similar to that obtained with Stau1DeltaNt88-HA3. Expression of increasing amounts of Stau155-HA3 or Stau1DeltaNt25-HA3 (Figure 7C) led to a comparable increases of Pr55Gag/Pr55Gag BRET ratio up to 2.16-2.34-fold (Figure 7D). In contrast, expression of Stau1DeltaNt37-HA3 or Stau1DeltaNt88-HA3 had no effect on Pr55Gag/Pr55Gag BRET ratio when their expression is relatively low. However, when highly expressed, they slightly enhanced the BRET ratio by 1.34-1.47-fold. These results suggest that the sequence located between amino acids 26 and 37 is important for Stau1-mediated enhancement of Pr55Gag multimerization and show that Stau1 acts on Pr55Gag multimerization in a dose-dependent manner.
###end p 58
###begin p 59
###xml 48 51 48 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55 </sup>
###xml 0 94 0 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Identification of the N-terminal region of Stau1<sup>55 </sup>as a regulatory sequence for HIV-1 assembly</bold>
###xml 96 103 96 103 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A, B) </bold>
###xml 186 188 186 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 210 214 210 214 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 290 291 290 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 450 454 438 442 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 590 591 578 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 602 609 590 597 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C, D) </bold>
###xml 627 630 615 618 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 635 639 623 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 711 714 699 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 715 716 703 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 733 736 721 724 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 798 802 786 790 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 963 967 943 947 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(D) </bold>
###xml 80 85 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Identification of the N-terminal region of Stau155 as a regulatory sequence for HIV-1 assembly. (A, B) 293T cells were transfected as described in Figure 4B but included additional Stau155-HA deletion mutants. (A) For each condition, an aliquot of the cells (providing equivalent total YFP/Rluc ratio) was used for Western blot analysis using anti (alpha)-HA and anti (alpha)-CA antibodies. Anti (alpha)-GAPDH antibody was used as a loading control. (B) Another aliquot of the cells was used for BRET assays. Calculated BRET ratios were plotted as a function of the corresponding total YFP/Rluc ratio. (C, D) Dose response pr55Gag/pr55Gag BRET assays. 293T cells were transfected with fixed amounts of pCMV-pr55Gag-Rluc and pCMV-pr55Gag-YFP and increasing amounts of different Stau1-HA expressors. (C) 48 hours later, half of the cells were lysed and analyzed by Western blotting using anti (alpha)-HA and anti (alpha)-GAPDH antibodies. *: Non-specific labelling.(D) The other half of the cells was used for BRET assays. BRET ratio is plotted as a function of the corresponding amount of transfected Stau1-HA expressor.
###end p 59
###begin title 60
Effect of Stau1 N-terminal mutants on VLP production
###end title 60
###begin p 61
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 194 204 194 200 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88 </sup>
###xml 221 225 217 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 249 250 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 295 305 291 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88 </sup>
###xml 364 368 356 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 384 386 376 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 389 391 381 383 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 399 408 391 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 411 413 399 401 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 551 553 539 541 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8A</xref>
###xml 613 615 601 603 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 618 620 606 608 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 731 735 719 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 792 801 780 785 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 804 806 788 790 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 927 931 911 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 988 990 972 974 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 993 995 977 979 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1003 1012 987 992 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 1015 1017 995 997 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1025 1027 1005 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8B</xref>
###xml 1051 1053 1031 1033 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 1061 1063 1041 1043 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1066 1068 1046 1048 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1212 1215 1192 1195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 1235 1244 1215 1220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 1360 1362 1336 1338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8C</xref>
###xml 1416 1425 1392 1397 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 1428 1430 1400 1402 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1473 1475 1445 1447 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1478 1479 1450 1451 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 1566 1575 1538 1543 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt25</sup>
###xml 1588 1597 1556 1561 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt37</sup>
###xml 1630 1639 1594 1599 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt25</sup>
###xml 1670 1679 1630 1635 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt37</sup>
###xml 1699 1701 1655 1657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8D</xref>
###xml 1784 1788 1740 1744 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
We already showed that Stau1 over-expression, likely as a consequence of its role in multimerization, also increases VLP release from the cell [51]. Therefore, considering the inability of Stau1DeltaNt88 to influence Pr55Gag multimerization (Figure 4), we suspected that over-expression of Stau1DeltaNt88 would not stimulate VLP production. To test this idea, Pr55Gag and either Stau155-HA3 or Stau1DeltaNt88-HA3 were co-expressed in 293T cells. Twenty-four hours post-transfection, the levels of VLP release were analyzed by Western blotting (Figure 8A). As expected, a 2-fold increase in the expression of Stau155-HA3 as compared to endogenous Stau1 resulted in a 2.5-fold increase in VLP release while the cellular level of Pr55Gag remained unchanged. In contrast, over-expression of Stau1DeltaNt88-HA3 did not stimulate VLP production. To confirm these results, dose-response assays were performed. Constant amounts of Pr55Gag were co-expressed with increasing amounts of either Stau155-HA3 or Stau1DeltaNt88-HA3 (Figure 8B). As previously shown [51], Stau155-HA3 over-expression stimulated VLP production in a dose-dependent manner up to 10-fold with no significant change in the intracellular level of Pr55Gag. In contrast, Stau1DeltaNt88-HA over-expression did not lead to a significant increase of VLP release, except at high expression levels (Figure 8C). However, the stimulation of VLP production by Stau1DeltaNt88-HA3 was always less than that produced by Stau155-HA3, when expressed at the same level. Analyses of VLP production in the presence of Stau1DeltaNt25-HA and Stau1DeltaNt37-HA indicated that, whereas Stau1DeltaNt25-HA enhanced VLP release, Stau1DeltaNt37-HA did not (Figure 8D) consistent with the conclusion that Stau1 molecular determinant for enhanced Pr55Gag multimerization is carried by amino acids 26 to 37.
###end p 61
###begin p 62
###xml 27 29 27 29 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 0 91 0 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Over-expression of Stau1-HA<sub>3 </sub>lacking amino acids 26 to 37 does not stimulate VLP production</bold>
###xml 148 152 148 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 175 179 175 179 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 193 197 193 197 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B) </bold>
###xml 220 222 220 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 225 227 225 227 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 235 244 235 240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 247 248 243 244 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 568 572 548 552 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(C) </bold>
###xml 587 591 567 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 749 751 729 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 754 756 734 736 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 765 774 745 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 777 778 753 754 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 792 793 768 769 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
Over-expression of Stau1-HA3 lacking amino acids 26 to 37 does not stimulate VLP production. 293T cells were transfected with a Rev-independent Pr55Gag expressor and constant (A) or increasing (B) amounts of either Stau155-HA3 or Stau1DeltaNt88-HA3-expressing plasmids. Twenty-four hours post-transfection, cells extracts and VLPs were prepared (see "Methods" section) and analyzed by Western blotting using anti (alpha)-Stau1, anti (alpha)-HA and anti (alpha)-CA antibodies. Anti (alpha)-calnexin antibodies were used as a loading control. *: Non-specific labelling. (C) Amounts of Pr55Gag in cell extracts and in VLP were quantitated using Quantity One (version 4.5) software (Bio-Rad) and plotted as a function of the amounts of transfected Stau155-HA3 and Stau1DeltaNt88-HA3-expressors. (D) Cells were transfected as in (A) with two additional N-terminal Stau1 mutants. Cell extracts and VLPs were prepared and analyzed as in (A).
###end p 62
###begin title 63
Discussion
###end title 63
###begin p 64
###xml 84 88 84 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 245 248 245 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 273 275 273 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 303 307 303 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 463 467 463 467 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 50 55 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We previously reported that Stau1 participates in HIV-1 assembly by influencing Pr55Gag multimerization [51]. However, very little is known about the molecular mechanisms underlying this process. In this report, we show that, in addition to Pr55Gag-binding via its dsRBD3 [51,52], Stau1's effect on Pr55Gag multimerization depends on amino acids located within its N-terminus. Moreover, we show important contributions from both NC zinc fingers for the Stau1/Pr55Gag interaction suggesting that Stau1 influences processes that depend on these NC sub-domains.
###end p 64
###begin p 65
###xml 141 142 141 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 747 751 747 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 795 797 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 798 800 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 518 523 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 634 639 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Gag mutants whose zinc fingers were disrupted, failed to interact with Stau1 as seen in BRET and co-immunoprecipitation assays (Figure 2). This suggests that Stau1 directly makes contact with these structures although we cannot rule out the possibility that these combined mutations affect the structure of other sub-domains of NC and potentially a Stau1-binding motif. Interestingly, viruses that harbour these mutations do not encapsidate Stau1 [53]. Although this phenotype could be attributed to the loss of HIV-1 genomic RNA packaging and to Stau1 RNA-binding activity, this strongly suggests that Stau1 encapsidation into HIV-1 may be achieved by the formation of a Stau1-Gag-RNA ternary complex where Stau1 interactions with both Pr55Gag and genomic RNA contribute to this process [51,52].
###end p 65
###begin p 66
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 226 230 226 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 242 243 242 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 247 249 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 357 361 357 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 984 987 984 987 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 1330 1332 1330 1332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 78 83 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 642 647 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 852 857 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1294 1299 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
NC zinc fingers are known to play important roles during several steps of the HIV-1 replication cycle such as genomic RNA packaging and reverse transcription [27-29,63]. In addition, they have been shown to be involved in Pr55Gag assembly [5,6,29,30,46,64]. Our results with the BRET assay that monitors direct interaction between wild type and mutated Pr55Gag proteins are consistent with these results. Whereas some studies reported dramatic defects in assembly and particle production only when both zinc fingers were disrupted [29,46], other showed that mutations in either of the NC zinc fingers (especially the C-terminal one) impaired HIV-1 assembly [30]. It is possible that the loss of one zinc finger can be compensated by the intact one and would explain why, in certain studies, single mutation within these motifs have no major effects on HIV-1 assembly. Interestingly, mutations in both zinc fingers are required for a complete loss of interaction between Stau1 and Pr55Gag, mutation in one zinc finger causing only a partial reduction. Therefore, through its interaction with the zinc fingers, Stau1 most likely influences steps of assembly that are controlled by the NC zinc fingers. In addition, we do not exclude the possibility that Stau1 also participates in other steps of HIV-1 life cycle that depend on NC [65].
###end p 66
###begin p 67
###xml 210 214 210 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 818 820 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 960 962 960 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 1429 1433 1429 1433 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 102 107 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 872 877 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1251 1256 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Although both Stau1 and the Gag-NC zinc fingers are engaged in specific interactions with the genomic HIV-1 RNA, we do not have any evidence that Stau1 interacts with NC via the genomic RNA since the Stau1-Pr55Gag association was shown to be resistant to RNase treatment [52]. Moreover, although the C15/49S NC mutant retains its ability to bind RNA nonspecifically through its basic amino acids [24-26], this mutant is unable to recruit Stau1 supporting the idea that Stau1/Gag-NC interaction is not bridged by RNA. Nevertheless, it is possible that Stau1-Gag-NC interactions favour recruitment of the genomic RNA and its subsequent trafficking and encapsidation. Indeed, mutating the conserved CCHC residues of the NC zinc fingers drastically impairs genomic RNA packaging in newly formed virions and that of Stau1 [53]. We previously showed that Stau1 association with HIV-1 genomic RNA is required for its subsequent encapsidation into the viral particle [53], our results now suggest that Stau1/Gag-NC interaction is also a critical determinant for this process. In addition, whether Stau1 interacts first with NC or with the genomic RNA to recruit the other partner or independently interacts with each of them through different pathways during HIV-1 assembly and RNA packaging processes is still unknown. The identification of a Stau1 mutant that retains its ability to associate with genomic RNA but is defective for Pr55Gag binding will help answer these questions.
###end p 67
###begin p 68
###xml 130 139 130 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 142 144 138 140 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 186 189 182 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 215 219 211 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 347 351 343 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 467 470 463 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 475 479 471 475 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 500 502 496 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 505 507 501 503 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 582 583 578 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 724 733 720 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 736 738 728 730 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 773 782 765 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 785 787 773 775 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1105 1115 1093 1099 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88 </sup>
###xml 1210 1214 1194 1198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1395 1397 1379 1381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 93 98 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 382 387 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1052 1057 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1134 1139 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1322 1327 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
We identified the first 88 amino acids of Stau1 as a regulatory motif of its activity during HIV-1 assembly. Indeed, whereas Stau1DeltaNt88-HA3 mutant is still able to interact with Pr55Gag, it fails to enhance Pr55Gag multimerization as seen by BRET, fractionation and VLP release assays. These results strongly suggest that Stau1-binding to Pr55Gag is not sufficient to influence HIV-1 assembly. They eliminate the possibility that the observed increase in the Pr55Gag/Pr55Gag BRET ratio upon Stau155-HA3 over-expression was the result of non-specific changes in the proximity of Rluc and YFP tags due to Stau1 recruitment towards assembly complexes. Similarly, the possibility of major overall structural changes in Stau1DeltaNt88-HA3 can be ruled out. Indeed, the Stau1DeltaNt88-HA3 mutant retains its capacity to homo-dimerize, to enhance translation of repressed mRNAs, to bind ribosomes and to associate with membranes (unpublished data). Consequently, this sequence probably confers highly specific functions to Stau1 that are advantageous for HIV-1 assembly. It will be interesting to study Stau1DeltaNt88 encapsidation into HIV-1 as a means to determine whether the Stau1-mediated enhancement of Pr55Gag multimerization is a prerequisite for its intraviral packaging or whether it relies on its association with HIV-1 genomic RNA and on the control of RNA selection for encapsidation [53].
###end p 68
###begin p 69
###xml 98 101 98 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag</sup>
###xml 149 153 149 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 281 285 281 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 373 377 373 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 500 504 500 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 730 735 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
How does this region control Stau1 activity? It is likely that Stau1, in conjunction with its Pr55Gag-binding activity, attracts host factors to Pr55Gag complexes that are crucial for assembly. NC-associated proteins that are also important for the transition between specific Pr55Gag assembly intermediates such as ABCE1 [44,45,47] are good candidates. Although ABCE1/Pr55Gag interaction depends on NC basic amino acids [46], the disruption of both NC zinc fingers resulted in the loss of ABCE1/Pr55Gag association by 80% [46]. Thus, it will be important to elucidate the functional relationship between Stau1 and NC-associated proteins to determine if their respective acquisition by assembly intermediates and functions during HIV-1 assembly are simultaneous or sequential.
###end p 69
###begin p 70
###xml 82 84 82 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink">26</sup>
###xml 95 97 95 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">37</sup>
###xml 141 145 141 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 814 816 814 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 817 819 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 820 822 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 1122 1124 1122 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 1125 1127 1125 1127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 1128 1130 1128 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 1147 1156 1147 1152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;Nt88</sup>
###xml 1159 1161 1155 1157 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1209 1211 1205 1207 <sup xmlns:xlink="http://www.w3.org/1999/xlink">55</sup>
###xml 1214 1216 1210 1212 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 1387 1394 1383 1390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 1488 1492 1484 1488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1511 1513 1507 1509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 1639 1643 1635 1639 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 1822 1824 1818 1820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 1849 1851 1845 1847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 524 529 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 709 714 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1042 1047 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1350 1355 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1737 1742 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1807 1812 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 1992 1997 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Within the first 88 N-terminal amino acids of Stau1, a region of 12 amino acids (M26RGGAYPPRYFY37) controls Stau1 functions in regard to Pr55Gag assembly. Post-translational modifications are very common among RNA-binding proteins such as hnRNPs and RNA helicase A and are known to regulate their cellular proteome, function and localization [66-69]. It is then conceivable that post-translational modification of Stau1's N-terminal region controls the recruitment of protein partners and/or modulates Stau1 function during HIV-1 assembly. Alternatively, the N-terminal sequence may recruit ubiquitin ligase through two potential ESCRT targeting domains (PPRY and YPFPVPPL) [50]. In most retroviruses (except HIV-1), the PPXY motif in Gag recruits a ubiquitin ligase and is required for virus budding and release [50,70,71]. Resulting ubiquitination allows targeting of the PPXY-containing protein to the ESCRT machinery located to the multivesicular bodies. Similarly, the YPX(n)L domain that is also present in some retroviruses (including HIV-1) recruits the AIP1/ALIX protein that also targets the cargo to the ESCRT [50,72,73]. Although Stau1DeltaNt88-HA3 associates with membrane as efficiently as Stau155-HA3 (data not shown), it is conceivable that these signals control the localization of Stau1 to specific membrane compartments to support HIV-1 assembly. Interestingly, Popov et al. recently showed that AIP1/ALIX, through its Bro1 domain, is able to bind the NC domain of Pr55Gag in addition to p6 [64]. Strikingly, this interaction requires the integrity of both zinc fingers and is RNA-independent, as observed for Stau1/Pr55Gag association. When over-expressed, AIP1/ALIX rescues the release defect of late domain-mutated HIV-1. Although AIP-1/ALIX over-expression has no effect on wild type HIV-1 release [74], in contrast to Stau1 [51], it is possible that Stau1 and AIP-1/ALIX, through their simultaneous or sequential association with the NC zinc fingers, cooperate during HIV-1 assembly. The putative interplay between AIP1/ALIX, ESCRTs and Stau1 during both wild type and L-domain-mutated virus assembly will be very interesting to explore in future studies.
###end p 70
###begin p 71
###xml 159 163 159 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 276 283 276 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#916;88</sup>
###xml 286 288 282 284 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3 </sub>
###xml 328 329 324 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 381 382 377 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 384 385 380 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 387 388 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8</xref>
###xml 493 495 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 571 577 567 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">oskar </italic>
###xml 726 732 722 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">oscar </italic>
###xml 766 768 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 220 225 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 310 315 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 403 413 <span type="species:ncbi:7227">Drosophila</span>
###xml 726 731 <span type="species:ncbi:50733">oscar</span>
Finally, our work highlights the modular nature of the Stau1 protein in the following ways. The double-stranded RNA binding domain (dsRBD3) interacts with Pr55Gag [52] whereas the N-terminus controls its activity during HIV-1 assembly. This is supported by the fact that Stau1Delta88-HA3 still associates with HIV-1 Gag (Figure 5) but fails to enhance its multimerization (Figures 4, 6, 8). Strikingly, Drosophila Stau1 orthologue, dStau, has also been shown to function as a modular protein [75]. The third dsRBD of dStau for example is involved in dStau association to oskar RNA whereas the second dsRBD is important for the microtubule-dependent transport of the mRNP and the fifth dsRBD is involved in the derepression of oscar mRNA translation, once localized [75].
###end p 71
###begin title 72
Conclusion
###end title 72
###begin p 73
###xml 97 101 97 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
###xml 116 121 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
In this study, we provide important new information about the determinants in both Stau1 and Pr55Gag that impact on HIV-1 assembly.
###end p 73
###begin title 74
Authors' contributions
###end title 74
###begin p 75
LCC participated in the design of the study, carried out most of the experiments and drafted the manuscript.
###end p 75
###begin p 76
###xml 68 70 68 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 75 77 75 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5E</xref>
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F8">8D</xref>
KB carried out the immunoprecipitation experiments shown in Figures 2D and 5E, contributed to figure 3B and 8D, reproduced the experiment shown in figure 8A and generated the Flag constructs.
###end p 76
###begin p 77
AJM participated in the design and coordination of the study and critically revised the manuscript.
###end p 77
###begin p 78
LDG participated in the design and coordination of the study and wrote the final version of the manuscript.
###end p 78
###begin p 79
All authors read and approved the final manuscript.
###end p 79
###begin title 80
Acknowledgements
###end title 80
###begin p 81
###xml 252 256 252 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">Gag </sup>
We thank Louise Cournoyer, Alexandre Desjardins, Alexandre Ben Amor and Celine Frechina for technical assistance, Miroslav Milev for critical comments on the manuscript, Dr. Eric Cohen for HxBRU PR-provirus, Dr. George Pavlakis for Rev-independent Pr55Gag expressor and Dr. Michel Bouvier for anti-Na-K ATPase.
###end p 81
###begin p 82
KB is a recipient of the Fonds de la Recherche en Sante du Quebec studentship. AJM is a recipient of a Canadian Institutes of Health Research (CIHR) New Investigator award. This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) to LDG (41596-04), grants from the CIHR to LDG (MOP-62751) and AJM (MOP-38111) and a New Opportunities Grant from the Canadian Foundation for Innovation to AJM.
###end p 82
###begin article-title 83
###xml 106 124 <span type="species:ncbi:11886">Rous sarcoma virus</span>
###xml 129 157 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Cryo-electron microscopy reveals conserved and divergent features of gag packing in immature particles of Rous sarcoma virus and human immunodeficiency virus
###end article-title 83
###begin article-title 84
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The stoichiometry of Gag protein in HIV-1
###end article-title 84
###begin article-title 85
###xml 65 68 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 73 102 <span type="species:ncbi:11723">simian immunodeficiency virus</span>
Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions
###end article-title 85
###begin article-title 86
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 and the host cell: an intimate association
###end article-title 86
###begin article-title 87
###xml 29 34 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Intracellular trafficking of HIV-1 Gag: how Gag interacts with cell membranes and makes viral particles
###end article-title 87
###begin article-title 88
###xml 15 50 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Assembling the human immunodeficiency virus type 1
###end article-title 88
###begin article-title 89
###xml 23 28 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 32 37 <span type="species:ncbi:9606">human</span>
Assembly of infectious HIV-1 in human epithelial and T-lymphoblastic cell lines
###end article-title 89
###begin article-title 90
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 egress is gated through late endosomal membranes
###end article-title 90
###begin article-title 91
###xml 11 16 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Infectious HIV-1 assembles in late endosomes in primary macrophages
###end article-title 91
###begin article-title 92
###xml 31 66 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Dynamic fluorescent imaging of human immunodeficiency virus type 1 gag in live cells by biarsenical labeling
###end article-title 92
###begin article-title 93
###xml 33 68 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body
###end article-title 93
###begin article-title 94
###xml 46 51 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly
###end article-title 94
###begin article-title 95
Visualization of retroviral replication in living cells reveals budding into multivesicular bodies
###end article-title 95
###begin article-title 96
###xml 42 47 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Plasma membrane is the site of productive HIV-1 particle assembly
###end article-title 96
###begin article-title 97
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 59 64 <span type="species:ncbi:9606">human</span>
HIV-1 buds predominantly at the plasma membrane of primary human macrophages
###end article-title 97
###begin article-title 98
###xml 11 46 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Productive human immunodeficiency virus type 1 assembly takes place at the plasma membrane
###end article-title 98
###begin article-title 99
###xml 0 5 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane
###end article-title 99
###begin article-title 100
###xml 12 47 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Analysis of human immunodeficiency virus type 1 Gag dimerization-induced assembly
###end article-title 100
###begin article-title 101
###xml 28 33 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Identification of a minimal HIV-1 gag domain sufficient for self-association
###end article-title 101
###begin article-title 102
###xml 72 77 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Identification of an intracellular trafficking and assembly pathway for HIV-1 gag
###end article-title 102
###begin article-title 103
###xml 111 146 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Formation of virus assembly intermediate complexes in the cytoplasm by wild-type and assembly-defective mutant human immunodeficiency virus type 1 and their association with membranes
###end article-title 103
###begin article-title 104
###xml 80 85 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Identification and characterization of virus assembly intermediate complexes in HIV-1-infected CD4+ T cells
###end article-title 104
###begin article-title 105
###xml 39 44 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Time course of Gag protein assembly in HIV-1-infected cells: a study by immunoelectron microscopy
###end article-title 105
###begin article-title 106
###xml 28 31 <span type="species:ncbi:103820">Gag</span>
###xml 32 35 <span type="species:ncbi:103820">Gag</span>
Role of RNA in facilitating Gag/Gag-Pol interaction
###end article-title 106
###begin article-title 107
###xml 18 53 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA
###end article-title 107
###begin article-title 108
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein
###end article-title 108
###begin article-title 109
###xml 14 49 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA
###end article-title 109
###begin article-title 110
###xml 51 86 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Mutations of RNA and protein sequences involved in human immunodeficiency virus type 1 packaging result in production of noninfectious virus
###end article-title 110
###begin article-title 111
###xml 78 113 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein
###end article-title 111
###begin article-title 112
###xml 14 19 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Intracellular HIV-1 Gag localization is impaired by mutations in the nucleocapsid zinc fingers
###end article-title 112
###begin article-title 113
###xml 41 76 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Analysis of the assembly function of the human immunodeficiency virus type 1 gag protein nucleocapsid domain
###end article-title 113
###begin article-title 114
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 80 115 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Human cellular nucleic acid-binding protein Zn2+ fingers support replication of human immunodeficiency virus type 1 when they are substituted in the nucleocapsid protein
###end article-title 114
###begin article-title 115
###xml 81 86 <span type="species:ncbi:9606">Human</span>
Mutations in the alpha-helix Directly C-terminal to the Major Homology Region of Human Immunodeficiency Virus Type 1 Capsid Protein Disrupt Gag Multimerization and Markedly Impair Virus Particle Production
###end article-title 115
###begin article-title 116
###xml 27 62 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Functional surfaces of the human immunodeficiency virus type 1 capsid protein
###end article-title 116
###begin article-title 117
###xml 27 62 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Assembly properties of the human immunodeficiency virus type 1 CA protein
###end article-title 117
###begin article-title 118
###xml 49 54 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Role of the major homology region in assembly of HIV-1 Gag
###end article-title 118
###begin article-title 119
###xml 27 62 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The C-terminal half of the human immunodeficiency virus type 1 Gag precursor is sufficient for efficient particle assembly
###end article-title 119
###begin article-title 120
###xml 55 90 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release
###end article-title 120
###begin article-title 121
###xml 80 115 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly
###end article-title 121
###begin article-title 122
###xml 118 153 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Characterization of a putative alpha-helix across the capsid-SP1 boundary that is critical for the multimerization of human immunodeficiency virus type 1 gag
###end article-title 122
###begin article-title 123
###xml 36 41 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Flexibility in the P2 domain of the HIV-1 Gag polyprotein
###end article-title 123
###begin article-title 124
###xml 43 48 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Helical structure determined by NMR of the HIV-1 (345-392)Gag sequence, surrounding p2: implications for particle assembly and RNA packaging
###end article-title 124
###begin article-title 125
###xml 9 12 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy
###end article-title 125
###begin article-title 126
Conservation of a stepwise, energy-sensitive pathway involving HP68 for assembly of primate lentivirus capsids in cells
###end article-title 126
###begin article-title 127
###xml 68 73 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Identification of a host protein essential for assembly of immature HIV-1 capsids
###end article-title 127
###begin article-title 128
###xml 81 86 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 143 148 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Basic residues in the nucleocapsid domain of Gag are required for interaction of HIV-1 gag with ABCE1 (HP68), a cellular protein important for HIV-1 capsid assembly
###end article-title 128
###begin article-title 129
###xml 33 36 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Host ABCE1 is at plasma membrane HIV assembly sites and its dissociation from Gag is linked to subsequent events of virus production
###end article-title 129
###begin article-title 130
###xml 40 45 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
The clathrin adaptor complex AP-1 binds HIV-1 and MLV Gag and facilitates their budding
###end article-title 130
###begin article-title 131
###xml 15 20 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
Interaction of HIV-1 Gag with the clathrin-associated adaptor AP-2
###end article-title 131
###begin article-title 132
Retrovirus budding
###end article-title 132
###begin article-title 133
###xml 42 77 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The host protein Staufen1 participates in human immunodeficiency virus type 1 assembly in live cells by influencing pr55Gag multimerization
###end article-title 133
###begin article-title 134
###xml 33 68 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Identification of Staufen in the human immunodeficiency virus type 1 Gag ribonucleoprotein complex and a role in generating infectious viral particles
###end article-title 134
###begin article-title 135
###xml 67 102 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidation
###end article-title 135
###begin article-title 136
Mammalian staufen is a double-stranded-RNA- and tubulin-binding protein which localizes to the rough endoplasmic reticulum
###end article-title 136
###begin article-title 137
###xml 2 7 <span type="species:ncbi:9606">human</span>
A human sequence homologue of Staufen is an RNA-binding protein that is associated with polysomes and localizes to the rough endoplasmic reticulum
###end article-title 137
###begin article-title 138
Kinesin transports RNA: isolation and characterization of an RNA-transporting granule
###end article-title 138
###begin article-title 139
Mammalian Staufen1 recruits Upf1 to specific mRNA 3'UTRs so as to elicit mRNA decay
###end article-title 139
###begin article-title 140
Interaction of Staufen1 with the 5' end of mRNA facilitates translation of these RNAs
###end article-title 140
###begin article-title 141
Staufen1 is imported into the nucleolus via a bipartite nuclear localization signal and several modulatory determinants
###end article-title 141
###begin article-title 142
###xml 20 55 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
###xml 113 116 <span type="species:ncbi:103820">Gag</span>
###xml 121 124 <span type="species:ncbi:103820">Gag</span>
Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation
###end article-title 142
###begin article-title 143
###xml 75 110 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
A novel fluorescence resonance energy transfer assay demonstrates that the human immunodeficiency virus type 1 Pr55Gag I domain mediates Gag-Gag interactions
###end article-title 143
###begin article-title 144
###xml 20 55 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Kinetic analysis of human immunodeficiency virus type 1 assembly reveals the presence of sequential intermediates
###end article-title 144
###begin article-title 145
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 nucleocapsid zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA
###end article-title 145
###begin article-title 146
###xml 0 35 <span type="species:ncbi:11676">Human immunodeficiency virus type 1</span>
Human immunodeficiency virus type 1 Gag engages the Bro1 domain of ALIX/AIP1 through the nucleocapsid
###end article-title 146
###begin article-title 147
###xml 93 121 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Properties, functions, and drug targeting of the multifunctional nucleocapsid protein of the human immunodeficiency virus
###end article-title 147
###begin article-title 148
Arginine methylation of RNA helicase a determines its subcellular localization
###end article-title 148
###begin article-title 149
The methylation of the C-terminal region of hnRNPQ (NSAP1) is important for its nuclear localization
###end article-title 149
###begin article-title 150
Asymmetric arginine dimethylation of heterogeneous nuclear ribonucleoprotein K by protein-arginine methyltransferase 1 inhibits its interaction with c-Src
###end article-title 150
###begin article-title 151
Arginine methylation facilitates the nuclear export of hnRNP proteins
###end article-title 151
###begin article-title 152
###xml 4 29 <span type="species:ncbi:11855">Mason-Pfizer monkey virus</span>
The Mason-Pfizer monkey virus PPPY and PSAP motifs both contribute to virus release
###end article-title 152
###begin article-title 153
Nedd4.1-mediated ubiquitination and subsequent recruitment of Tsg101 ensure HTLV-1 Gag trafficking towards the multivesicular body pathway prior to virus budding
###end article-title 153
###begin article-title 154
###xml 35 40 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
###xml 48 52 <span type="species:ncbi:11665?1.0">EIAV</span>
AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding
###end article-title 154
###begin article-title 155
###xml 23 26 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
The protein network of HIV budding
###end article-title 155
###begin article-title 156
###xml 17 52 <span type="species:ncbi:11676">human immunodeficiency virus type 1</span>
Potent rescue of human immunodeficiency virus type 1 late domain mutants by ALIX/AIP1 depends on its CHMP4 binding site
###end article-title 156
###begin article-title 157
Distinct roles of two conserved Staufen domains in oskar mRNA localization and translation
###end article-title 157

